Bristol Myers

0:02:46

The state of pharmaceuticals: Bristol-Myers Squibb's plan to buy RayzeBio

0:10:09

Bristol Myers Squibb - SOTYKTU™ for Treatment of Moderate-to-Severe Plaque Psoriasis

0:02:32

Bristol Myers Squibb, the renowned US based global drug maker, has made headlines in India

0:03:13

Bristol Myers Squibb | Patient Stories: Meet Latarsha

0:02:53

Bristol Myers Squibb | Flexible Ways of Working

0:02:19

Bristol-Myers Squibb to pay trainees

0:03:53

Bristol-Myers Squibb Aktienanalyse 2024: Wie sicher ist die Dividende? (+günstig bewertet?)

0:00:21

Bristol-Myers Squibb Explained!

0:01:38

Interview with Pinal Patel from Bristol-Myers Squibb

0:02:40

Our Patient & Employee Stories: Latina’s Story | Bristol Myers Squibb

0:07:26

Bristol-Myers Squibb CEO: The Real Value in Acquiring Celgene | Mad Money | CNBC

0:02:01

Bristol-Myers Squibb to acquire Mirati in deal worth up to $5.8B

0:14:20

Bristol Myers Squibb Aktie // Jetzt noch aufspringen, bevor der Zug weg ist?

0:00:53

How To Login To Bristol-Myers Squibb Employee Portal (2024) | BMS Employee Sign In

0:02:50

Our Patient & Employee Stories: Matt’s Story | Bristol Myers Squibb

0:00:59

Dr. George Yohrling, Bristol Myers Squibb

0:00:21

Why Jim Cramer Dislikes Major Pharma and Bristol Myers Stock #shorts

0:02:34

Bristol-Myers Squibb CEO on $13 billion MyoKardia acquisition: 'potentially revolutionary medicine'

0:00:43

Bristol Myers Squibb plans $2 billion in cost cuts by 2027

0:02:54

Our Patient & Employee Stories: Alicia's Story | Bristol Myers Squibb

0:02:08

Our Patient & Employee Stories: Jim’s Story | Bristol Myers Squibb

0:20:47

Bristol Myers Squibb Aktie - Top Zahlen, hohe Dividendenrendite, aber sinkende Umsätze 2025 und 2026

0:03:42

Shaping more sustainable IT procurement with Lenovo and Bristol Myers Squibb

0:01:16

Bristol-Myers Squibb stock tumbles after stroke drug trial sees mixed results